RI
Regenxbio Inc
🇩🇪XSTU.RB0GermanyHealthcare
€6.77EURup +0.04 (+0.59%)OpenEnd of day7:43 AM
Price€6.77+0.04 (+0.59%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US75901B1070
- CUSIP
- Not reported
Company
- Employees
- 371
- Headquarters
- Rockville, United States
- Website
- https://www.regenxbio.com
- CEO
- Mr. Curran M. Simpson M.S.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $174.48M+12%up year on year
- Net income
- -$196.43M-11.88%down year on year
- Gross margin
- 54.22%-32.17%down year on year
- Free cash flow
- -$249.67M-175.25%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.